FindTrial
Sign In

The efficacy of EzeCheck device for its use in the Gynecologic department.

Noninvasive detection of Hemoglobin, bilirubin, oxygen saturation, creatinine and other basic healthcare parameter using EzeCheck device for across age groups.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044952
Enrollment
300
Registered
2022-08-26
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94-O9A- Other obstetric conditions, not elsewhere classified

Interventions

Intervention1: NA: NA

Sponsors

Partha Pratim Das Mahapatra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All female patients who have undergone delivery and prescribed for the Hemoglobin test.

Exclusion criteria

Exclusion criteria: Applied Mehndi on finger tip or have any skin disease which can affect the upper dermal layer.

Design outcomes

Primary

MeasureTime frame
Efficacy of the non-invasive device for determining the Hb levels.Timepoint: 4 weeks—

Secondary

MeasureTime frame
Efficacy of the device in detecting post-partum anemia cases.Timepoint: 1 month—

Countries

India

Contacts

Public ContactDr Nirmal Mohakud

Kalinga Institute of Medical Science

nirmal.mahakud@kims.ac.in9437365233

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026